Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients by Derya Gül Bilen, Abdullah Atlı, Betül Uyar

Subjects: Get full text

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies by Madera JJ, Such P, Zhao C, Baker RA

Subjects: Get full text

The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia by Kruti Joshi, Lian Mao, David M. Biondi, Robert Millet

Subjects: Get full text

Prescribing practice of long-acting injectable antipsychotics by Jisha M Lucca, Ghada AlSumain, Maryam Almousa, Rehab Alkhalifa

Subjects: Get full text

Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety by Barnett J, Pappa S

Subjects: Get full text

The combination of long-acting injectable antipsychotics, a new key in resistant schizophrenia by M.F. Tascón Guerra, A. Osca Oliver, M.V. López Rodrigo, M. Palomo Monge, M. Pérez Fominaya

Subjects: Get full text

Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations by Orietta Zaniolo, Gianni Ghetti, Massimiliano Povero, Lorenzo Pradelli

Subjects: “…long-acting injectable antipsychotics…”
Get full text

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study by Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll, Klaus Wiedemann

Subjects: “…Long-acting injectable…”
Get full text

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy by Lorie Benning, Andrea Mantsios, Deanna Kerrigan, Jenell S. Coleman, Elizabeth Golub, Oni Blackstock, Deborah Konkle-Parker, Morgan Philbin, Anandi Sheth, Adaora A. Adimora, Mardge H. Cohen, Dominika Seidman, Joel Milam, Seble G. Kassaye, Tonya Taylor, Miranda Murray

Subjects: Get full text

Attitudes Toward Long-Acting Injectable Antipsychotics among Schizophrenia Patients in Southern Thailand: A Multihospital-Based Cross- Sectional Survey by Jarurin Pitanupong, Apinan Karakate, Laddaporn Tepsuan, Grittin Sritrangnant

Subjects: Get full text

Appropriate use of single-dose injectable aripiprazole lauroxil in the treatment of schizophrenia by Rachael C. Davis, BS, Jianing Xu, MS, Daniel B. Hall, PhD, Xianyan Chen, PhD, Michaelyn M. Moretz, Henry N. Young, PhD, Joshua Caballero, PharmD, BCPP, FCCP

Subjects: “…long-acting injectable antipsychotics…”
Get full text

Attitudes and perceptions about the use of long-acting injectable antipsychotics among behavioral health practitioners by Shaina Schwartz, PharmD, BCPP, Christina Carilli, Taimur Mian, MD, Laura Ruekert, PharmD, BCPP, BCGP, Archana Kumar, MD

Subjects: “…long-acting injectable…”
Get full text

The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia by Milz R, Benson C, Knight K, Antunes J, Najarian D, Lopez Rengel PM, Wang S, Richarz U, Gopal S, Kane JM

Subjects: Get full text

Searching for a long-acting injectable formulation for the antiretroviral dolutegravir by Anderson Aparecido de Marchi, Claudia Bandeira Kobarg, Keity Margareth Doretto, Luis Gustavo Robello, Maiara Cássia Pigatto, Marilene Alves, Renar Pereira Santos Pereira

Subjects: Get full text

Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population by Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Hargarter L

Subjects: “…long-acting injectable…”
Get full text

Poly(ethylene glycol)-<i>b</i>-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables by Marie-Emérentienne Cagnon, Silvio Curia, Juliette Serindoux, Jean-Manuel Cros, Feifei Ng, Adolfo Lopez-Noriega

Subjects: Get full text

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation by Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E

Subjects: “…long-acting injectable…”
Get full text

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan by Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N

Subjects: Get full text

TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia by Citrome L, Suett M, Franzenburg KR, Eshet R, Elgart A, Davis GL 3rd, Harary E, Tohami O, Mychaskiw MA, Kane JM

Subjects: Get full text

Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review by Amber N. Edinoff, Prithvi K. Doppalapudi, Claudia Orellana, Caroline Ochoa, Shelby Patti, Yahya Ghaffar, Elyse M. Cornett, Aaron J. Kaye, Omar Viswanath, Omar Viswanath, Omar Viswanath, Ivan Urits, Ivan Urits, Adam M. Kaye, Alan D. Kaye

Subjects: Get full text